Successful management of chylothorax with etilefrine: case report in 2 pediatric patients
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Muniz, GysellaHidalgo-Campos, Jennifer
Valdivia-Tapia, Maria del Carmen
Shaikh, Nader
Carreazo, Nilton Yhuri
Issue Date
2018-05xmlui.metadata.dc.contributor.email
[email protected]
Metadata
Show full item recordPublisher
American Academy of PediatricsJournal
PediatricsDOI
10.1542/peds.2016-3309Abstract
Chylothorax is defined as the accumulation of chyle within the pleural space. Originally described in 1917 by Pisek, it is the most common cause of pleural effusion in the neonatal period. The leading cause of chylothorax is laceration of the thoracic duct during surgery, which occurs in 0.85% to 6.6% of children undergoing cardiothoracic surgery. Few authors of reports in the literature have looked at etilefrine, a relatively unknown sympathomimetic, as an option for the medical treatment of chylothorax. In this case report, we review the clinical course of 2 infants with type III esophageal atresia who developed chylothorax after thoracic surgery and were successfully treated with intravenous etilefrine after failing initial dietary and pharmacological management.Type
info:eu-repo/semantics/articleRights
info:eu-repo/semantics/restrictedAccessLanguage
engDescription
El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.ISSN
0031-40051098-4275
ae974a485f413a2113503eed53cd6c53
10.1542/peds.2016-3309
Scopus Count
Collections